You buy from eMAG, Fashion Days,, through our affiliate links and help finance the site. It doesn't cost you anything extra, but it helps us to develop this project. Thank you!

Canceled or delayed flights? >>Claim compensation NOW<< for delayed or canceled flight and you can receive up to 600 € compensation!

COVID-19 Daily - September 29, 2021: Pfizer began clinical trial of an anti-covid pill; Russia reported a record number of deaths; Joe Biden received the third dose

0 191

Large pharmaceutical companies continue research in order to produce new anti-COVID vaccines, but also to be able to launch more effective pills and treatments against the new coronavirus. All the while, there are countries reporting a record number of deaths and infected people. Below you have some of the most important information about COVID-19:

  • Pfizer has started a clinical study of a pill that aims to stop the progression of COVID-19 infections. Pfizer is one of the companies in the pharma sector that works on oral "antivirals" whose role is to stop infections with the new coronavirus, similar to existing flu drugs.
  • Russia reported the highest daily number of deaths COVID-19 - 852 deaths - recorded in the last 24 hours. The new figures bring the total death toll in Russia to 205.531, the largest number in Europe.
  • MEPs in Northern Ireland have agreed to end social distance requirements in shops and theaters, but not in accommodation units,  starting Thursday. Belfast ministers have said that wearing a mask will remain a mandatory requirement in stores, which is a violation of the laws of other British nations.
  • French pharmaceutical company Sanofi says it will abandon plans for a mRNA-based COVID-19 vaccine. Pfizer-BioNTech and Moderna vaccines have proven to be effective and safe.
  • US President Joe Biden receives third dose of anti-covid, Pfizer-BioNTech. He agreed to get vaccinated in front of the cameras to encourage Americans to get vaccinated with the third dose.
Leave A Reply

Your email address Will not be published.